Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years

被引：0
|
作者：
Charles Oo
George Hill
Albert Dorr
Baolian Liu
Samuel Boellner
Penelope Ward
机构：
[1] Roche Global Development,
[2] Aventis Pharmaceutical Inc. 1041,undefined
[3] Roche Global Development,undefined
[4] XIQ Coordination Inc.,undefined
[5] Clinical Study Center,undefined
[6] Roche Global Development,undefined
来源：
European Journal of Clinical Pharmacology | 2003年 / 59卷
关键词：
Oseltamivir; Children;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：411 / 415
页数：4
相关论文
共 50 条
  • [21] Cardiohemodynamic and Electrophysiological Effects of Anti-influenza Drug Oseltamivir In Vivo and In Vitro
    Ken Kitahara
    Yuji Nakamura
    Yayoi Tsuneoka
    Satomi Adachi-Akahane
    Hikaru Tanaka
    Hiroshi Yamazaki
    Akira Takahara
    Junichi Yamazaki
    Takanori Ikeda
    Atsushi Sugiyama
    Cardiovascular Toxicology, 2013, 13 : 234 - 243
  • [22] In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate
    Ilyushina, Natalia A.
    Donnelly, Raymond P.
    ANTIVIRAL RESEARCH, 2014, 111 : 112 - 120
  • [23] Oseltamivir, an anti-influenza virus drug, produces hypothermia in mice: Comparison among Oseltamivir, Zanamivir and Diclofenac
    Ono, Hideki
    Nagano, Yuko
    Matsunami, Noriaki
    Sugiyama, Shinichi
    Yamamoto, Shohei
    Tanabe, Mitsuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (04) : 638 - 642
  • [24] Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs
    Tao, Jiaye
    Wang, Heping
    Wang, Wenjian
    Mi, Na
    Zhang, Wei
    Wen, Qiujia
    Ouyang, Jiajing
    Liang, Xinyun
    Chen, Min
    Guo, Wentao
    Li, Guoming
    Liu, Jun
    Zhao, Hanning
    Wang, Xin
    Li, Xuemeng
    Feng, Shengjun
    Liu, Xinguang
    He, Zhiwei
    Zhao, Zuguo
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (07)
  • [25] Efficacy of anti-influenza peptide vaccine in aged mice
    Ben-Yedidia, T
    Abel, L
    Arnon, R
    Globerson, A
    MECHANISMS OF AGEING AND DEVELOPMENT, 1998, 104 (01) : 11 - 23
  • [26] Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo
    Chand, P
    Bantia, S
    Kotian, PL
    El-Kattan, Y
    Lin, TH
    Babu, YS
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (12) : 4071 - 4077
  • [27] Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
    Bantia, S
    Parker, CD
    Ananth, SL
    Horn, LL
    Andries, K
    Chand, P
    Kotian, PL
    Dehghani, A
    El-Kattan, Y
    Lin, T
    Hutchison, TL
    Montgomery, JA
    Kellog, DL
    Babu, YS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) : 1162 - 1167
  • [28] Influence of Prior Influenza Vaccination on Current Influenza Vaccine Effectiveness in Children Aged 1 to 5 Years
    Matsumoto, Kazuhiro
    Fukushima, Wakaba
    Morikawa, Saeko
    Fujioka, Masashi
    Matsushita, Tohru
    Kubota, Megumi
    Yagi, Yoshina
    Takasaki, Yoshio
    Shindo, Shizuo
    Yamashita, Yuji
    Yokoyama, Takato
    Kiyomatsu, Yumi
    Hiroi, Satoshi
    Nakata, Keiko
    Maeda, Akiko
    Kondo, Kyoko
    Ito, Kazuya
    Kase, Tetsuo
    Ohfuji, Satoko
    Hirota, Yoshio
    VACCINES, 2021, 9 (12)
  • [29] Fate of new three anti-influenza drugs and one prodrug in the water environment
    Azuma, Takashi
    Ishida, Mao
    Hisamatsu, Kanae
    Yunoki, Ayami
    Otomo, Kana
    Kunitou, Mari
    Shimizu, Mai
    Hosomaru, Kaori
    Mikata, Shiori
    Mino, Yoshiki
    CHEMOSPHERE, 2017, 169 : 550 - 557
  • [30] Electropharmacological characterization of microminipigs as a laboratory animal using anti-influenza virus drug oseltamivir
    Lubna, Nur Jaharat
    Nakamura, Yuji
    Hagiwara-Nagasawa, Mihoko
    Goto, Ai
    Chiba, Koki
    Kitta, Kumiko
    Izumi-Nakaseko, Hiroko
    Ando, Kentaro
    Naito, Atsuhiko T.
    Akie, Yasuki
    Sugiyama, Atsushi
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2018, 43 (7-9): : 507 - 512
12345